MBF Therapeutics
Ambler
About MBF Therapeutics
MBF Therapeutics is a clinical-stage animal health company focusing on the development of gene-based, immunotherapeutic vaccines for use in veterinary medicine. Using proprietary vaccine platform and delivery system technology, MBF Therapeutics’ checkpoint inhibitor therapies have the potential of transforming the treatment of cancer and prevention of infectious diseases in companion animals and livestock.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $851.0K
- Funding stage: Seed
- Last round: Grant (Dec 2021)
- Website: mbftherapeutics.com
- Phone: 215-620-3699
Industries & Categories
Biotechnology, Life Science, Oncology, Therapeutics, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/mbf-therapeutics-109189 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.